1. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005– 2007) 
O. Lortholary, J.-P. Gangneux, K. Sitbon, B. Lebeau, F. de Monbrison, Y. Le Strat, B. Coignard, F. Dromer, S. Bretagne 
Clinical Microbiology and Infection 
Volume 17, Issue 12, Pages (December 2011)
DOI: /j x
Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
Overall survival at 3 months after diagnosis of invasive aspergillosis. (a) Patients diagnosed either with one (plain line) or with at least two mycological (dashed line) criteria. (b) Patients given any antifungal regimens containing voriconazole, either alone (plain line) or in combination (dotted line), or any antifungal regimens without voriconazole (dashed line).
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions